Human Peptide Transporter Deficiency: Importance of HLA-B in the Presentation of TAP-Independent EBV Antigens

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4555-4563

  De La Salle, Henri ^a,l   Houssaint, Elisabeth ^b   Peyrat, Marie Alix ^b   Arnold, Danièle ^c,k   Salamero, Jean ^d   Pinczon, Delphine ^b   Stevanovic, Stefan ^c   Bausinger, Huguette ^a   Fricker, Dominique ^a   Gomard, Elisabeth ^e   Biddison, William ^f   Lehner, Paul ^g   Uytdehaag, Fons ^h   Sasportes, Maryline ⁱ   Donato, Lionel ^j   Rammensee, Hans Georg ^c,k   Cazenave, Jean Pierre ^a   Hanau, Daniel ^a   Tongio, Marie Marthe ^a   Bonneville, Marc ^b,l  

^a INSERM   (France)

^b INSTITUT DE BIOLOGIE   (France)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d INSTITUT CURIE   (France)

^e INSTITUT COCHIN   (France)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j HÔPITAL DE HAUTEPIERRE   (France)

^k Institut für Zellbiologie   (Germany)

^l ETS de Strasbourg   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; HLA B ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; TAP2 PROTEIN, HUMAN; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; GENETICS; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; ATP-BINDING CASSETTE TRANSPORTERS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HERPESVIRUS 4, HUMAN; HLA-B ANTIGENS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE ACTIVATION; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 0031569976     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
2. Wei, M. L., and P. Creswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
3. Schirmbeck, R., and J. Reimann. 1994. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur. J. Immunol. 24:1478.
4. Gabathuler, R., G. Reid, G. Kolaitis, J. Driscoll, and W. A. Jefferies. 1994. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J. Exp. Med. 180:1415.
5. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264.
6. Hosken, N. A., and M. J. Bevan. 1992. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J. Exp. Med. 175:719.
7. Esquivel, F., J. Yewdell, and J. J. Bennink. 1992. RMA-S cells present endogenously synthesized cytosolic proteins to class I restricted cytotoxic lymphocytes. J. Exp. Med. 175:163.
8. Zhou, X., R. Glas, T. Liu, H. G. Ljunggren, and M. Jondal. 1993. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb. Eur. J. Immunol. 23:1802.
9. Zweerink H. J., M. C. Gammon, U. Utz, S. Y. Sauma, T. Harrer, J. C. Hawkins, R. P. Johnson, A. Sirotina, J. D. Hermes, B. D. Walker, and W. E. Biddison. 1993. Presentation of endogenous peptides to MHC class I-restricrted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763.
10. + CTL. J. Immunol. 154:6140.
11. Lee, S., W. Thomas, N. Blake, and A. Rickinson. 1996. Transporter (TAP)-independent processing of a multiple membrane-spaning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol 26:1875.
12. Khanna, R., S. R. Burrows, D. J. Moss, and S. L. Silins. 1996. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implication for cytotoxic T-lymphocyte control of EBV-associated malignancies. J. Virol. 70:5357.
13. + T cells. Cell 71:1205.
14. + T cells in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA 91:6525.
15. Ljunggren, H. G., L. Van Kaer, P. G. Ashtonrickardt, S. Tonegawa, and H. L. Ploegh. 1995. Differential reactivity of residual CD8(+) T lymphocytes in TAP1 and beta 2-microglobulin mutant mice. Eur. J. Immunol. 25:174.
16. Glas, R., C. Ohlen, F. Hoglund, and K. Karre. 1994. The CD8(+) T cell repertoire in beta(2)-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibilily class I. J. Exp. Med. 179:661.
17. de la Salle, H., D. Hanau, D. Flicker, A. Urlacher, A. Kelly, J. Salamero, S. H. Powis, L. Donato, H. Bausinger, M. Laforet, M. Jeras, D. Spehner, T. Bieber, A. Falkenrodt, J.-P. Cazenave, J. Trowsdale, and M.-M. Tongio. 1994. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265:237.
18. Donato, L., H. de la Salle, D. Hanau, M.-M. Tongio, M. Oswald, A. Vandevenne, and J. Geisert. 1995. Association of HLA class I antigen deficiency related to a TAP-2 gene mutation with familial bronchiectasis. J. Pediatr. 127:895.
19. Davodeau, F., M. A. Peyrat, I. Houde, M. N. Hallet, H. Vié, and M. Bonneville. 1993. Peripheral selection of antigen receptor junctional features in a major human γδ subset. Eur. J. Immunol. 23:804.
20. Vié, H., S. Chevalier, R. Garand, J. P. Moisan, V. Praloran, M. C. Devilder, J. F. Moreau, and J. P. Soulillou. 1989. Clonal expansion of lymphocytes bearing the γδ T cell-receptor in a patient with a large granular lymphocyte disorder. Blood 74:285.
21. Brichard, V., A. Van Pel, T. Wölfel, B. Lethé, P. G. Coulie, and T. Boom. 1993. The tyrosinase gene codes for an antigen recognised by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
22. Scotet, E., J. David-Ameline, M. A. Peyrat, A. Moreau-Aubry, D. Pinczon, A. Lim, J. Even, G. Semana, J. M. Berthelot, R. Breathnach, M. Bonneville, and E. Houssaint. 1996. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184:1791.
23. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, Wehi 164 clonne 13, for measuring cytotoxic factor/necrosis factor from human monocytes. J. Immunol. Methods 95:99.
24. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Ramensee. 1991. Allele specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
25. Hildebrand, W. H., J. D. Domena, S. Y. Shen, M. Lau, P. I. Terasaki, M. Bunce, S. G. E. Marsh, M. G. Guttridge, W. B. Bias, and P. Parham. 1994. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens 43:209.
26. Moreau, J. F., M. Bonneville, M. A. Peyrat, A. Godard, Y. Jacques, C. Desgranges, and J. P. Soulillou. 1986. T lymphocyte cloning from rejecting human kidney allografts: growth frequency and functional/phenotypic analysis. J. Clin. Invest. 78:874.
27. Maguchi, M., W. Nishida, K. Kohara, A. Kuwano, I. Kondo, and K. Hiwada. 1995. Molecular cloning and gene mapping of human basic and acidic calponins. Biochem. Biophys. Res. Commun. 217:238.
28. Vorechovsky, I., D. Vetrie, J. Holland, D. R. Bentley, K. Thomas, J.-N. Zhou, L. D. Notarangelo, A. Plebani, G. Fontan, H. D. Ochs, L. Hammarström, P. Sideras, and C. I. E. Smith. 1994. Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22. Genomics 21:517.
29. Baas, E. J., H.-M. van Santen, M. J. Kleijmeer, H. J. Geuze, P. J. Peters, and H. L. Ploegh. 1992. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J. Exp. Med. 176:147.
30. + T cell repertoire that display both diversity and peptide specificity. Eur. J. Immunol. 26:288.
31. Rieux-Laucat, F., F. Le Deist, F. Selz, A. Fisch, and J.-P. de Villartay. 1994. Normal T cell receptor Vβ usage in a primary immunodeficiency associated with HLA class II deficiency. Eur. J. Immunol. 23:928.
32. van Eggermond, M. C. I. A., G. T. Rijkers, W. Kuis, B. J. M. Zegers, and P. J. van den Elsen. 1993. T cell development in a major histocompatibility complex class II-deficient patient. Eur. J. Immunol. 23:2585.
33. - population with altered physicochemical properties of complementarity-determining region 3. J. Immunol. 156:895.
34. Brock, R., K.-H. Weismüller, G. Jung, and P. Walden. 1996. Molecular basis for the recognition of two structurally different major histocompatibility complex/ peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93: 13108.
35. Srivastva, P. K., H. Udono, and Z. Li. 1994. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93.
36. Androlewicz, M. J., B. Ortmann, P. M. Vanendert, T. Spies, and P. Cresswell. 1994. Characteristics of peptide and major histocompatibility complex class I beta(2)-microglubulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. USA 91:12716.
37. Caligiuri, M., C. Murray, D. Buchwald, H. Levine, P. Chenay, D. F. Peterson, A. Komaroff, and J. Ritz. 1987. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139:3306.